Simplex Trading’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,900
Closed -$9.2K 9574
2025
Q4
$9.2K Sell
5,900
-11,900
-67% -$21.2K ﹤0.01% 7039
2025
Q3
$36K Sell
17,800
-249,100
-93% -$570K ﹤0.01% 6770
2025
Q2
$616K Buy
266,900
+238,100
+827% +$1.75M ﹤0.01% 3285
2025
Q1
$224K Buy
28,800
+100
+0.3% +$794 ﹤0.01% 4192
2024
Q4
$134K Buy
28,700
+19,600
+215% +$102K ﹤0.01% 4910
2024
Q3
$49K Sell
9,100
-4,900
-35% -$34.8K ﹤0.01% 5900
2024
Q2
$123K Buy
14,000
+13,700
+4,567% +$135K ﹤0.01% 5153
2024
Q1
$3K Sell
300
-5,900
-95% -$71.3K ﹤0.01% 8262
2023
Q4
$69K Sell
6,200
-800
-11% -$6.71K ﹤0.01% 5765
2023
Q3
$47K Buy
7,000
+6,500
+1,300% +$53.9K ﹤0.01% 5863
2023
Q2
$4K Buy
+500
New +$4.02K ﹤0.01% 8046
2023
Q1
Sell
-1,400
Closed -$8K 9522
2022
Q4
$8K Sell
1,400
-4,300
-75% -$30.5K ﹤0.01% 7730
2022
Q3
$35K Buy
5,700
+4,000
+235% +$35.1K ﹤0.01% 6887
2022
Q2
$15K Sell
1,700
-13,900
-89% -$103K ﹤0.01% 7874
2022
Q1
$131K Buy
15,600
+14,000
+875% +$126K ﹤0.01% 5762
2021
Q4
$16K Sell
1,600
-1,700
-52% -$25.2K ﹤0.01% 8613
2021
Q3
$60K Hold
3,300
﹤0.01% 7296
2021
Q2
$57K Buy
+3,300
New +$44.5K ﹤0.01% 7480

Other funds holding INMB

Simplex Trading's INMB Position: Q1 2026 in Review

Simplex Trading reduced its INmune Bio (INMB) stake by 58% in Q1 2026, selling an estimated $6.59K and leaving 3,366 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8057.

Simplex Trading first reported a position in INMB in Q2 2021 and has held it in 17 quarters since. The position peaked at $334K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Simplex Trading held 3,366 shares of INmune Bio worth $3.8K as of Q1 2026.
  • Simplex Trading sold 4,623 INmune Bio shares in Q1 2026, an estimated $6.59K.
  • INmune Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8057 holding.
  • Simplex Trading first reported a position in INmune Bio in Q2 2021 and has held it in 17 quarters since.
  • Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.